27th Annual Perspectives in Urology: Point Counterpoint
November 9-11, 2018
The 27th Annual Perspectives in Urology: Point Counterpoint will bring together leading experts to discuss and debate the latest in diagnosis, treatment, and ongoing research in the field of urology. The conference will contain lectures, debates, case presentations, interactive discussions, and interactive question and answer sessions. The use of cutting-edge audience response technology will allow for more fluid interaction among attendees, between attendees and faculty, and for more efficient exchange of knowledge than traditional education formats.
This three-day CME-accredited conference brings together expert faculty to give lectures, interactive discussions, panel discussions, debates, and case reports. This conference is designed for urologists, urologic oncologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and management of urologic diseases.
This conference is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of urologic diseases.
E. David Crawford, MD
Professor of Surgery, Urology and Radiation Oncology
E. David Crawford Endowed Chair in Urologic Oncology
University of Colorado, Denver
E. David Crawford is Professor of Surgery, Urology, and Radiation Oncology, and Head of the Section of Urologic Oncology at the University of Colorado Denver (UCD) in Denver, Colorado. He is also the E. David Crawford Endowed Chair in Urologic Oncology at UCD. Dr. Crawford received his medical degree from the University of Cincinnati. His postgraduate training included an internship and residency in Urology at the Good Samaritan Hospital in Cincinnati. He was subsequently awarded a Genitourinary Cancer fellowship with Dr. Donald G. Skinner at the University of California Medical Center in Los Angeles. Dr. Crawford is a nationally recognized expert in prostate cancer. The recipient of more than 69 research grants, he has conducted research in the treatment of advanced bladder cancer, metastatic adenocarcinoma of the prostate, hormone-refractory prostate cancer, and other areas of urological infections and malignancies. He has authored or coauthored more than 400 articles, which have been published in such journals as Urology, The New England Journal of Medicine, and the Journal of the National Cancer Institute. He has published five textbooks. He is also an editorial reviewer or consultant for a large number of publications, including Urology, Journal of Urology, The New England Journal of Medicine, Cancer, and the Journal of Clinical Oncology. He serves as Medical Editor of Grand Rounds in Urology. Dr. Crawford is an active member of many national and international organizations, including the American Society of Clinical AUA, he is a member of the Committee to Study Urologic Research Funding and the Prostate Cancer Clinical Trials Subcommittee. He currently serves on the board of governors, the GU committee, and the scientific advisory board of the Southwest Oncology Groups, and he chairs the national Prostate Conditions Education Council (PCEC).